期刊文献+

HPLC法测定人血浆中奥美拉唑及代谢物的浓度 被引量:1

Determination of the concentration of omperazole and its metabolite in human plasma by HPLC
下载PDF
导出
摘要 目的建立人血浆中奥美拉唑及5-羟奥美拉唑的高效液相色谱分析方法. 方法对羟基苯甲酸乙酯为内标,待测血浆以二氯甲烷提取,并进行高效液相紫外检测,色谱柱为Kromasit C18,5μm,4.6mm×150mm;流动相为0.1mol·L^-1乙酸铵-乙晴-甲醇(55:45:5),流速1.0 mL·min^-1,检测波长302nm,柱温:室温. 结果血浆中奥美拉唑及5-羟奥美拉唑的线性范围分别为0.005~2.001mg·L^-1和0.02~1.20mg·L^-1,相关系数分别为0.9989和0.9982,相对回收率分别为:93.2%~96.4%,92.5%~97.4%;日内日间变异均小于8%,最低检测限分别为0.005mg·L^-1及0.02mg·L^-1. 结论 HPLC法测定人血浆中奥美拉唑及5-羟奥美拉唑的浓度结果满意,可用于以奥美拉唑为探针药物,分析人群细胞色素氧化酶CYP2C19的表型多态性. Objective To establish a HPLC method for determining the concentrations of omeprazole and its metabolite 5 - hydroxyomeprazole in human plasma. Methods The internal standard was ethyl p - Hydroxybenzoate. Omeprazole and 5 - hydroxyomeprazole were extracted with diehloromethane and then separated on Kromasit C18(5μm,4.6mm× 150mm) with a mobile phase consisting of 0. 1 mol· L^-1 ammonium acetate : aeetonitrile: methanol (55:45:5) . The flow rate was 0.1 mol· L-^1. The detection was set on 302nm. Results The calibration curve was linear within 0.005 - 2. 001 mg· L^- 1 for omeprazole and 0.02 - 1.20mg· L^- 1 for 5 - hydroxyomeprazole, The relative recovery rates of omeprazle and 5 - hydroxyomeprazole were 93.2% - 96.4% and 92.5% - 97.4% , respectively. The RSD in a day and the RSD between days were both less than 8% . Conclusion HPLC is s simple, rapid and accurate method for determination of the concentrations of omeprazole and 5 - hydroxyomeprazole in human plasma in addition to the study of phenotype of eytochrome P450 2C19 in Hainan Li ethnic group.
出处 《中国热带医学》 CAS 2006年第6期962-963,共2页 China Tropical Medicine
关键词 奥美拉唑 5-羟奥美拉唑 高效液相色谱法 血浆 Omeprazole 5 - hydroxyomeprazole HPLC Plasma
  • 相关文献

参考文献2

二级参考文献13

  • 1[1]de Morais SM, Wilkinson GR, Blaisdell J, Nakamura K, Meyer UA, Goldstein JA. The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans[J]. J Biol Chem, 1994, 269(22):15419-15422. 被引量:1
  • 2[2]Balian JD, Sukhova N, Harris JW, Hewett J, Pickle L, Goldstein JA, et al. The hydroxylation of omeprazole correlates with S-mephenytoin metabolism: a population study[J]. Clin Pharmacol Ther, 1995, 57(6):662-669. 被引量:1
  • 3[3]Garcia-Encina G, Farran R, Puig S, Martinez L. Validation of an automated liquid chromatographic method for omeprazole in human plasma using on-line solid-phase extraction[J]. J Pharm Biomed Anal, 1999, 21(2):371-382. 被引量:1
  • 4[4]Fu LQ,Huang F, Wu DZ, Guo JH. The plasma concentration of omeprazole and metabolites 5′-hydroxyomeprazole, omeprazole sulphone are determinated by HPLC[J]. Chin Pharmacol Bull(中国药理学通报), 2002, 18(3):342-344. 被引量:1
  • 5[5]Chang M, Tybring G, Dahl ML, Gotharson E, Sagar M, Seensalu R, et al. Interphenotype differences in disposition and effect on gastrin levels of omeprazole-suitability of omeprazole as a probe for CYP2C19[J]. Br J Clin Pharmacol, 1995, 39(5):511-518. 被引量:1
  • 6[6]Andersson T, Andren K, Cederberg C, Lagerstrom PO, Lundborg P, Skanberg I. Pharmacokinetics and bioavai- lability of omeprazole after single and repeated oral administration in healthy subjects[J]. Br J Clin Pharmacol, 1990, 29(5):557-563. 被引量:1
  • 7[7]Andersson T, Regardh CG, Dahl-Puustinen ML, Bertilsson L. Slow omeprazole metabolizers are also poor S-mephenytoin hydroxylators[J]. Ther Drug Monit, 1990, 12(4):415-416. 被引量:1
  • 8[8]Sohn DR, Kobayashi K, Chiba K, Lee KH, Shin SG, Ishizaki T. Disposition kinetics and metabolism of omeprazole in extensive and poor metabolizers of S-mephenytoin 4′-hydroxylation recruited from an Oriental population[J]. J Pharmacol Exp Ther, 1992, 262(3):1195-1202. 被引量:1
  • 9[9]Howden CW. Clinical pharmacology of omeprazole[J]. Clin Pharmacokinet, 1991, 20(1):38-49. 被引量:1
  • 10[10]Maton PN. Omeprazole[J]. N Engl J Med, 1991, 324(14):965-975. 被引量:1

共引文献45

同被引文献5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部